4//SEC Filing
Loxo Oncology, Inc. 4
Accession 0001140361-16-069587
CIK 0001581720operating
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:44 PM ET
Size
5.4 KB
Accession
0001140361-16-069587
Insider Transaction Report
Form 4
Naider Avi Z.
Director
Transactions
- Award
Director Stock Option (right to buy)
2016-06-10+7,812→ 7,812 totalExercise: $24.18Exp: 2026-06-09→ Common Stock (7,812 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 12 equal monthly installments beginning one month after the grant date, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.
Documents
Issuer
Loxo Oncology, Inc.
CIK 0001581720
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001581720
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 4:44 PM ET
- Size
- 5.4 KB